BHARTIARTL vs DRREDDY: Stock Comparison

Bharti Airtel Ltd vs Dr Reddys Laboratories LtdUpdated 26 Aug 26, 4:08 PM ISTNSE & company filings

Bharti Airtel Ltd is the larger company by market capitalisation. Bharti Airtel Ltd shows a higher ROE, a higher dividend yield and faster revenue growth, while Dr Reddys Laboratories Ltd shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BHARTIARTL leads 10; DRREDDY leads 3 of 13

Not a rating
These companies operate in different sectors (Telecommunication vs Healthcare). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BHARTIARTLDRREDDY

Valuation lens

What price are you paying?

Market CapContext only
₹11.67 L Cr
₹99,326 Cr
P/E RatioDRREDDY has the lower reading
40.94x
30.85x
P/B RatioDRREDDY has the lower reading
7.94x
2.62x
EPSBHARTIARTL has the higher reading
₹47.79
₹39.75
Book ValueContext only
₹259.48
₹460.31
Dividend YieldBHARTIARTL has the higher reading
1.24%
0.67%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BHARTIARTL is the larger company
₹11.67 L Cr vs ₹99,326 Cr
P/E Ratio
DRREDDY has a lower P/E
30.85x vs 40.94x
P/B Ratio
DRREDDY has a lower P/B
2.62x vs 7.94x
EPS
BHARTIARTL has higher earnings per share
₹47.79 vs ₹39.75
Dividend Yield
BHARTIARTL has a higher dividend yield
1.24% vs 0.67%
Revenue Growth (TTM YoY)
BHARTIARTL has faster revenue growth
15.7% vs -11.6%
EPS Growth (TTM YoY)
BHARTIARTL has faster EPS growth
-34% vs -86.2%
Qtr Sales Growth
BHARTIARTL has stronger quarterly sales growth
15.7% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBHARTIARTLDRREDDY
SectorTelecommunicationHealthcare
IndustryTelecom - Cellular & Fixed line servicesPharmaceuticals

Price

MetricBHARTIARTLDRREDDY
Live Price₹1,902.1₹1,182
Day Change-2.31%-0.96%
Volume45.53 L19.93 L
52-Week High₹2,174.5₹1,414.9
52-Week Low₹1,740.5₹1,101
Distance from 52W High-12.53%-16.46%

Valuation

MetricBHARTIARTLDRREDDY
Market Cap₹11.67 L Cr₹99,326 Cr
P/E Ratio40.94x30.85x
P/B Ratio7.94x2.62x
EPS₹47.79₹39.75
Book Value₹259.48₹460.31
Dividend Yield1.24%0.67%

Growth

MetricBHARTIARTLDRREDDY
Revenue Growth (TTM YoY)15.7%-11.6%
EPS Growth (TTM YoY)-34%-86.2%
Qtr Sales Growth15.7%-11.5%
Qtr Profit Growth-16.5%-86.1%

Profitability & Leverage

MetricBHARTIARTLDRREDDY
ROE20.3%11.2%
ROCE17.6%13%
Net Margin14.96%12.76%
Operating Margin55.2%19.2%
Debt to Equity1.31x0.2x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBHARTIARTLDRREDDY
Promoter Holding40.47%26.64% 0.01 pp
FII Holding27.12% 0.68 pp32.07% 1.01 pp
DII Holding21.26% 0.61 pp31.74% 1.02 pp
Public Holding2.71% 0.07 pp9.35% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bharti Airtel Ltd and Dr Reddys Laboratories Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.